Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time

Duration of initial disease response remains a strong prognostic factor in multiple myeloma (MM) particularly for upfront autologous hematopoietic cell transplant (AHCT) recipients. We hypothesized that new drug classes and combinations employed prior to AHCT as well as after post-AHCT relapse may h...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Leukemia
Päätekijät: Kumar, Shaji K, Dispenzieri, Angela, Fraser, Raphael, Mingwei, Fei, Akpek, Gorgun, Cornell, Robert, Kharfan-Dabaja, Mohamed, Freytes, Cesar, Hashmi, Shahrukh, Hildebrandt, Gerhard, Holmberg, Leona, Kyle, Robert, Lazarus, Hillard, Lee, Cindy, Mikhael, Joseph, Nishihori, Taiga, Tay, Jason, Usmani, Saad, Vesole, David, Vij, Ravi, Wirk, Baldeep, Krishnan, Amrita, Gasparetto, Cristina, Mark, Tomer, Nieto, Yago, Hari, Parameswaran, D’Souza, Anita
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5871538/
https://ncbi.nlm.nih.gov/pubmed/29263438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2017.331
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia